EP 1368031 A2 20031210 - METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
Title (en)
METHOD OF TREATING OF DEMYELINATING DISEASES OR CONDITIONS
Title (de)
VERFAHREN ZUR BEHANDLUNG VON DEMYELINISIERENDEN ERKRANKUNGEN
Title (fr)
METHODE DESTINEE AU TRAITEMENT DE PATHOLOGIES OU DE TROUBLES LIES A LA DEMYELINISATION
Publication
Application
Priority
- GB 0119435 A 20010809
- US 0205501 W 20020214
- US 26884601 P 20010215
Abstract (en)
[origin: WO02064126A2] N-(Pyridinyl)-1H-indol-1-amines of formula I provide a unique combination of blocking properties for both the potassium and sodium channels. These compounds are useful for the treatment of Demyelinating Diseases and Conditions such as Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury and Stroke. The compounds are also useful for Stroke Rehabilitation, the treatment of Bladder Irritation and Dysfunction, and the treatment of Neuropathic Pain and Chemokine-Induced Pain.
IPC 1-7
IPC 8 full level
C07D 401/12 (2006.01); A61K 31/4439 (2006.01); A61P 3/00 (2006.01); A61P 9/00 (2006.01); A61P 13/00 (2006.01); A61P 13/10 (2006.01); A61P 17/02 (2006.01); A61P 19/02 (2006.01); A61P 25/00 (2006.01); A61P 25/02 (2006.01); A61P 25/28 (2006.01); A61P 27/02 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP KR US)
A61K 31/4439 (2013.01 - EP KR US); A61P 3/00 (2018.01 - EP); A61P 9/00 (2018.01 - EP); A61P 9/10 (2018.01 - EP); A61P 13/00 (2018.01 - EP); A61P 13/02 (2018.01 - EP); A61P 13/10 (2018.01 - EP); A61P 17/02 (2018.01 - EP); A61P 19/00 (2018.01 - EP); A61P 19/02 (2018.01 - EP); A61P 19/08 (2018.01 - EP); A61P 25/00 (2018.01 - EP); A61P 25/02 (2018.01 - EP); A61P 25/04 (2018.01 - EP); A61P 25/28 (2018.01 - EP); A61P 27/02 (2018.01 - EP); A61P 29/00 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02064126 A2 20020822; WO 02064126 A3 20030220; AP 1749 A 20070613; AP 2003002834 A0 20030930; AR 035750 A1 20040707; AU 2002247200 B2 20071213; AU 2002247200 B9 20080710; AU 2008201179 A1 20080403; AU 2008201179 B2 20090820; AU 2009238332 A1 20091210; BR 0207272 A 20040210; CA 2438712 A1 20020822; CN 100522164 C 20090805; CN 1529598 A 20040915; CN 1679564 A 20051012; CO 5390085 A1 20040430; CR 7023 A 20031117; CZ 20032172 A3 20040114; EA 011319 B1 20090227; EA 012409 B1 20091030; EA 200300882 A1 20031225; EA 200600896 A1 20060825; EC SP024218 A 20030924; EE 200300363 A 20031015; EP 1368031 A2 20031210; GB 0119435 D0 20011003; HK 1080361 A1 20060428; HK 1080361 B 20091030; HR P20030652 A2 20050630; HU P0303203 A2 20031229; HU P0303203 A3 20071128; IL 157341 A0 20040219; IL 157341 A 20101130; JP 2004518711 A 20040624; JP 2009185045 A 20090820; JP 2010120958 A 20100603; KR 100951540 B1 20100409; KR 100951542 B1 20100409; KR 20040014459 A 20040214; KR 20090005254 A 20090112; KR 20090005255 A 20090112; MA 26152 A1 20040701; ME P21208 A 20100610; MX PA03006110 A 20050701; MY 157745 A 20160715; NO 20033622 D0 20030814; NO 20033622 L 20031006; NZ 527011 A 20050729; NZ 539159 A 20061130; NZ 544720 A 20070831; NZ 556697 A 20090131; OA 12549 A 20060605; PA 8540101 A1 20030905; PE 20040175 A1 20040329; PL 363638 A1 20041129; SG 134170 A1 20070829; SK 10392003 A3 20040108; TR 200301330 T2 20041221; TR 200800691 T2 20080321; TR 200800692 T2 20080321; TR 200800693 T2 20080721; TW I325319 B 20100601; UA 80394 C2 20070925; UA 88773 C2 20091125; US 2003105150 A1 20030605; US 2004157888 A1 20040812; US 2004157889 A1 20040812; US 2005159456 A1 20050721; US 2005234105 A1 20051020; US 2006025452 A1 20060202; US 2009209594 A1 20090820; US 2009209595 A1 20090820; US 2009270458 A1 20091029; US 2009281147 A1 20091112; US 6967210 B2 20051122; US 7179821 B2 20070220; US 7230015 B2 20070612; US 7534803 B2 20090519; YU 62903 A 20060525; ZA 200306124 B 20041108
DOCDB simple family (application)
US 0205501 W 20020214; AP 2003002834 A 20020214; AR P020100540 A 20020215; AU 2002247200 A 20020214; AU 2008201179 A 20080313; AU 2009238332 A 20091119; BR 0207272 A 20020214; CA 2438712 A 20020214; CN 02804864 A 20020214; CN 200510059734 A 20020214; CO 02013025 A 20020215; CR 7023 A 20030716; CZ 20032172 A 20020214; EA 200300882 A 20020214; EA 200600896 A 20020214; EC SP024218 A 20020215; EE P200300363 A 20020214; EP 02714974 A 20020214; GB 0119435 A 20010809; HK 06100186 A 20060105; HR P20030652 A 20030813; HU P0303203 A 20020214; IL 15734102 A 20020214; IL 15734103 A 20030811; JP 2002563920 A 20020214; JP 2009091807 A 20090406; JP 2010030929 A 20100216; KR 20037010691 A 20020214; KR 20087031854 A 20081229; KR 20087031855 A 20020214; MA 27235 A 20030711; ME P21208 A 20020214; MX PA03006110 A 20020214; MY PI20020518 A 20020215; NO 20033622 A 20030814; NZ 52701102 A 20020214; NZ 53915902 A 20020214; NZ 54472002 A 20020214; NZ 55669702 A 20020214; OA 1200300199 A 20020214; PA 8540101 A 20020218; PE 2002000159 A 20020226; PL 36363802 A 20020214; SG 2005058029 A 20020214; SK 10392003 A 20020214; TR 200301330 T 20020214; TR 200800691 T 20020214; TR 200800692 T 20020214; TR 200800693 T 20020214; TW 91102861 A 20020215; UA 2003098376 A 20020214; UA A200603708 A 20060404; US 23614505 A 20050927; US 42038109 A 20090429; US 42039009 A 20090429; US 42040709 A 20090429; US 42041609 A 20090429; US 7619102 A 20020214; US 77065504 A 20040203; US 77065604 A 20040203; US 7932705 A 20050314; US 7936605 A 20050314; YU P62903 A 20020214; ZA 200306124 A 20030807